Template Synthesis of a Tris(bipyridyl) Receptor
1375
Fe(II) complex of a new tripodal (pseudo cage) ligand showing
an extended helical structure. Further, in the solid state the
arrangement is effectively ‘capped’ through symmetrical hydro-
gen bond interactions with an axially aligned PFꢀ6 counter ion.
8.1, 1H), 8.36 (d, 3J 8.1, 1H), 8.48 (dd, 4J 1.8, 5J 0.6, 1H), 8.63
(d, 4J 2.4, 1H). dC 18.60, 43.36, 120.98, 121.07, 133.10, 134.05,
137.39, 137.93, 149.15, 149.70, 153.05, 156.27. m/z (ESI-
HRMS) Calc. for [M þ H]þ ¼ 219.0683, found 219.0676; calc.
for [M þ Na]þ ¼ 241.0503, found ¼ 241.0497.
Experimental
2-((50-Methyl-[2,2’-bipyridin]-5-yl)methoxy)
benzaldehyde (6)
All reagents were of analytical grade unless otherwise indicated.
Chromatography grade solvents were distilled through a frac-
A
DMF (10 cm3) solution of salicylaldehyde (230 mg,
1
tionation column packed with glass helices. H and 13C NMR
1.88 mmol) and 5-chloromethyl-50-methyl-2,20-bipyridine
(343 mg, 1.57 mmol) in the presence of K2CO3 (650 mg,
4.7 mmol) was stirred at room temperature for 10 h. H2O
(20 cm3) was then added to the reaction mixture, and the
resulting precipitate was filtered off and washed with water
followed by a minimum volume of chilled MeOH. The crude
product was purified by chromatography on silica gel with
dichloromethane (98.75 %), MeOH (1 %) and saturated NH3
(0.25 %) as eluent to afford the product (477 mg, 94 %) as a
white solid. dH 2.41 (s, 3H), 5.27 (s, 2H), 7.06 (d, 3J 8.4 Hz, 1H),
7.13 (dd, 3J 7.8, 3J 7.2, 1H), 7.56 (ddd, 3J 8.4, 3J 7.8, 4J 1.8, 1H),
7.67 (dd, 3J 8.1, 4J 1.5, 1H), 7.88 (dd, 3J 7.8, 4J 1.8, 1H), 7.93
(dd, 3J 8.1, 4J 2.1, 1H), 8.31 (d, 3J 8.1, 1H), 8.45 (d, 3J 8.1, 1H),
8.53 (d, 4J 1.5, 1H), 8.75 (d, 4J 2.1, 1H), 10.55 (s, 1H). dC 18.64,
68.19, 113.01, 121.24, 121.27, 121.68, 125.42, 129.02, 131.77,
134.31, 136.18, 136.55, 138.46, 148.39, 149.32, 152.76, 155.88,
160.73, 189.62. m/z (ESI-HRMS) Calc. for [M þ Na]þ ¼
327.1104, found ¼ 327.1117.
spectra were recorded on a Bruker AM-300 or a Varian Mercury
300 MHz spectrometer (300.133 MHz) at 298 K. NMR of
organic species was recorded in CDCl3 and for metal complexes
in CD3CN. 1H and 13C NMR resonance are quoted in ppm and
the coupling constants (J) in Hertz (Hz). 1H NMR spectra were
referenced according to residual proton resonances for CDCl3
(7.24 ppm) and CD3CN (1.94 ppm). 13C NMR spectra were
referenced to solvent peaks for CDCl3 (77.0 ppm) and CD3CN
(1.39 ppm). Positive ion electrospray ionization high resolution
(ESI-HR): Fourier transform ion cyclotron resonance mass
spectrometry (FTICR-MS) measurements were obtained on a
Bruker BioAPEX 47e mass spectrometer equipped with an
Analytica of Branford electrospray ionization (ESI) source.
Microanalyzes were performed by the Campbell Microanalyti-
cal Laboratory, Chemistry Department, University of Otago,
Dunedin.
5-Trimethylsilylmethyl-50-methyl-2,20-bipyridine (4)
Lithium diisopropylamide (LDA) was prepared by adding 1.5 M
n-BuLi (4.4 cm3) dropwise to a stirred solution of dry diiso-
propylamine (0.758 g, 7.5 mmol) in THF (15 cm3) at ꢀ788C.
This solution was stirred for a further 0.5 h and allowed to warm
to 08C for 10 min. The resulting LDA solution was cooled to
ꢀ788C and a solution of 5,50-dimethyl-2,20-bipyridine (552 mg,
3 mmol) in THF was added dropwise. The reaction was allowed
to continue for 2 h and Me3SiCl (760 mg, 7 mmol) was then
added rapidly and the reaction was quenched with 3 cm3 of
MeOH after 3 min. The solvent was then removed under vacuum
and the resulting paste was taken up in dichloromethane and the
solution filtered. The dichloromethane was then removed under
vacuum and the solid that remained was purified by chroma-
tography on deactivated silica gel with 60 % petroleum and 40 %
ethyl acetate as eluent to afford the product as a waxy white solid
(614 mg, 80 %). dH 0.02 (s, 9H), 2.11 (s, 2H), 2.38 (s, 3H), 7.44
(dd, 3J 8.3, 4J 2.1, 1H), 7.61 (ddd, 3J 8.1, 4J 2.1, 5J 0.6, 1H), 8.22
(d, 3J 8.3, 1H), 8.24 (d, 3J 8.1, 1H), 8.34 (d, 4J 2.1, 1H), 8.48 (dd,
[FeHL](PF6)3ꢁCH3CN (L 5 3)
Astirredsolutionof 2-(50-methyl-[2,20]bipyridinyl-5-ylmethoxy)-
benzaldehyde 6 (61 mg, 0.2 mmol) and Fe(BF4)2ꢁ6H2O (23 mg,
0.067 mmol) in acetonitrile (10 cm3) was refluxed for 40 min
(for the 1H NMR spectrum of [Fe(6)3](BF4)2, see Fig. 3b). The
reaction mixture was cooled to room temperature and further
acetonitrile (90 cm3) added. To this, NH4OAc (77 mg,
1.0 mmol) was added and the resulting mixture stirred for 0.5 h.
The reaction mixture was then cooled to 08C in an ice bath
followed by the addition of NaCNBH3 (124 mg, 2.0 mmol).
After 2 h the reaction mixture was allowed to warm to room
temperature and stirred overnight and the solvent volume was
reduced under vacuum to ,5 cm3 and excess KPF6 in H2O
(15 cm3) was added. The resulting precipitate was isolated by
filtration and washed with H2O and a minimum volume of cold
MeOH then purified by chromatography on silica gel with
CH3CN, H2O, and saturated KNO3 (7 : 1 : 0.5) as eluent. The
product was then isolated as its PF6 salt (see above) affording a
purplish red solid (51 mg, 55 %). dH 2.24 (s, 9H), 3.94 (d, 2J 13.2,
3H), 4.01 (d, 2J 13.2, 3H), 5.04 (d, 2J 12.0, 3H), 5.09 (d, 2J 12.0,
3H), 7.05 ꢀ 7.20 (m, 12H), 7.41 (br s, 3H), 7.54 (ddd, 3J 7.5, 3J
7.5, 4J 1.8, 3H), 7.80 (br s, 3H), 7.98 (d, 3J 8.3, 3H), 8.02 (d, 3J
5
4J 2.1, J 0.6, 1H). dC ꢀ1.79, 18.55, 24.21, 120.44, 120.64,
133.12, 136.46, 136.65, 137.81, 148.47, 149.57, 152.27, 153.80.
5-Chloromethyl-50-methyl-2,20-bipyridine (5)
A solution of 5-trimethylsilylmethyl-50-methyl-2,20-bipyridine
(475 mg, 1.85 mmol), hexachloroethane (876 mg, 3.70 mmol)
and anhydrous CsF (562 mg, 3.70 mmol) in acetonitrile (20 cm3)
was heated at 608C with stirring for 6 h. The acetonitrile was
removed and replaced with dichloromethane (50 cm3) and the
resulting mixture was filtered. The filtrate was washed with
water (30 cm3) then brine (30 cm3) and was then dried over
anhydrous Na2SO4. The solvent was removed under vacuum
and the solid that remained was chromatographed on silica gel
with dichloromethane (97.5 %), MeOH (2 %) and saturated NH3
(0.5 %) as eluent to afford the pure product (344 mg, 85 %) as a
white crystalline solid. dH 2.37 (s, 3H), 4.62 (s, 2H), 7.62 (ddd, 3J
8.1, 4J 1.8, 5J 0.6, 1H), 7.82 (dd, 3J 8.1, 4J 2.4, 1H), 8.27 (d, 3J
3
3
8.3, 3H), 8.44 (d, J 8.3, 3H), 8.49 (d, J 8.3, 3H). dC 18.11,
51.64, 67.20, 112.37, 121.90, 123.74, 123.97, 132.70, 133.88,
136.52, 138.05, 138.88, 139.47, 152.29, 154.44, 156.45, 157.45,
157.42, 159.53. m/z (ESI-HRMS) Calc. for [M ꢀ 3PF6]3þ
¼
312.7822, found ¼ 312.7834. Anal. Calc. for C57H52FeN7O3P3F18ꢁ
CH3CN: C 50.08, H 3.92, N 7.92. Found: C 50.15, H 4.03,
N 8.02.
The deprotonated form of this compound was obtained by
treatment of the CD3CN NMR sample with K2CO3. dH 2.20 (s,
9H), 3.08 (d, 2J 11.4, 3H), 3.21 (d, 2J 11.4, 3H), 4.92 (d, 2J 12.7,
3H), 5.14 (d, 2J 12.7, 3H), 6.87 – 6.99 (m, 9H), 7.09 (d, 4J 0.9,
3
4
3
3H), 7.94 (dd, J 8.3, J 1.8, 6H), 8.00 (br s, 3H), 8.41 (d, J